Hypothesis

Transient, germline‑style selection bottlenecks can be imposed on aged somatic tissues to purge damaged cells and restore functional capacity without compromising tissue architecture.

Mechanistic Rationale

Germline immortality relies on three interconnected “cheats”: (1) constitutive telomerase activity that maintains telomere length [11101843]; (2) wave‑like epigenetic reprogramming that erases age‑associated marks [sciadv.ade1257]; and (3) a mitochondrial bottleneck coupled with heightened apoptosis that selects mutation‑free organelles [PMC5797848]. Somatic cells suppress these programs because evolution favored short‑term survival over perpetual fidelity (disposable soma theory). However, recent work shows that partial epigenetic reprogramming with OSK factors can reset age in vivo while preserving identity [acel.12877], indicating that the germline toolkit is modular.

We hypothesize that the missing link is the selective elimination step. In the germline, DNA damage triggers a p53‑independent apoptotic cascade mediated by TAp73 and PUMA that efficiently removes compromised gametes [PMC5797848]. Somatic tissues retain the apoptotic machinery but lack the damage‑sensing amplification that couples lesions to cell death. By briefly expressing a germline‑specific damage amplifier (e.g., the PIWI‑interacting RNA pathway component MIWI or the germ‑cell‑specific transcription factor BLIMP1/PRDM14) in aged somatic cells, we can convert sub‑lethal DNA lesions into a death signal, thereby imposing a germline‑grade selection bottleneck. Coupled with intermittent telomerase activation (via TERT‑ERT2) and a short pulse of OSK‑mediated epigenetic reset, this triad should allow somatic tissues to shed damaged cells, repopulate from healthy progenitors, and thereby regain youthful function.

Experimental Design

1. Model – Progeroid Ercc1^−/− mice and naturally aged C57BL/6J mice (24 mo).
2. Inducible constructs –
   • TERT‑ERT2 (4‑OHT inducible telomerase).
   • OSK (doxycycline‑inducible Oct4, Sox2, Klf4).
   • BLIMP1‑PRDM14 bicistronic vector (tamoxifen‑inducible Cre‑loxP).
3. Regimen – Monthly cycles: 2 days 4‑OHT (telomerase), followed by 2 days doxycycline (OSK), then 2 days tamoxifen (BLIMP1/PRDM14), with a 2‑week washout between cycles. Total 3 months.
4. Readouts –
   • Tissue‑specific functional assays (grip strength, treadmill endurance).
   • Telomere length (Q‑FISH).
   • Mitochondrial mutation load (Duplex‑seq).
   • Epigenetic age (mouse Horvath clock).
   • Apoptosis rates (cleaved caspase‑3 IHC) and progenitor proliferation (Ki‑67, Pax7).
   • Histological architecture (H&E, Masson’s trichrome).
5. Controls – Each factor alone, vehicle, and wild‑type young mice.

Predictions and Falsifiability

• Primary prediction – Combined germline‑style selection will improve functional performance (>20 % increase in grip strength) and reduce epigenetic age (>1.5 years reversal) without causing fibrosis or tumorigenesis.
• Falsification – If the triple regimen fails to improve function beyond single‑factor controls, or if it leads to excessive loss of tissue mass (>15 % atrophy) or tumorigenic outgrowth, the hypothesis is refuted.
• Mechanistic falsifiability – Blocking apoptosis with a pan‑caspase inhibitor (Z‑VAD‑FMK) during the BLIMP1/PRDM14 pulse should abolish the regenerative benefit, confirming that selective cell death is essential.